Clinical trial Recruiting at 1 site Interventional Ages 19 to 40 Women only

Effects of different medications on uterine and umbilical vessel function during cesarean deliveries

Official title: Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study

Run by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · NCT04053478 · Data updated 2026-11-12

This study is testing how different medications used during cesarean deliveries affect blood flow in the uterus and umbilical cord to see which ones are best for keeping mothers and babies healthy.

Quick facts

Study typeInterventional
Ages19 Years to 40 Years
SexWomen only
Enrollment144 (estimated)
SponsorSamuel Lunenfeld Research Institute, Mount Sinai Hospital
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJuly 8, 2019
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedApril 6, 2026
Trial IDNCT04053478 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women aged 19-40, at 37-41 weeks of gestation, who are undergoing elective cesarean deliveries under spinal anesthesia.

Probably not a fit

Patients who are in labor, require general anesthesia, or have certain medical conditions affecting uterine contractility may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how various vasopressors, including ephedrine, phenylephrine, norepinephrine, and vasopressin, affect the contractility of human myometrium and umbilical vessels in an in-vitro setting. By isolating these tissues, the research aims to eliminate clinical confounding variables and directly compare the effects of these medications on uteroplacental blood flow and fetal health. The findings could provide critical insights into the optimal management of hypotension during cesarean deliveries, which is a common complication affecting many mothers and their newborns.

Why it matters

Potential benefit: If successful, this study could lead to improved management of hypotension during cesarean deliveries, enhancing maternal and neonatal outcomes.

How similar studies have gone: While there have been studies on vasopressor use in obstetrics, this specific in-vitro approach to directly compare their effects on myometrial and umbilical vessel function is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who give written consent to participate in this study
* Patients with gestational age 37-41 weeks
* Patients of 19-40 years
* Non-laboring patients, not exposed to exogenous oxytocin
* Patients requiring elective primary or first repeat caesarean delivery
* Patients undergoing caesarean delivery under spinal anesthesia

Exclusion Criteria:

* Patients who refuse to give written informed consent
* Patients who require general anesthesia
* Patients in labor and those receiving oxytocin for induction of labor
* Emergency caesarean delivery in labor
* Patients who have had previous uterine surgery or \>1 previous caesarean delivery
* Patients with any condition predisposing to uterine atony
* Patients on medications that could affect myometrial contractility, such as insulin, nifedipine, labetolol or magnesium sulfate.

Where it's running

  • Mount Sinai Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.